使用分子印制聚合物对5-HT1A受体抗剂进行查
Naphtali A O'Connor1, David A Paisner, Donna Huryn
1Department of Chemistry, University of California, Irvine, California 92717, USA.
Journal of the American Chemical Society
|February 8, 2007
概括
分子印记聚合物 (MIP) 模仿药物发现查的原生受体. 研究人员发现了MIPs和血清素5-HT1A受体之间的相关性,这表明MIPs可以作为受体代用物.
科学领域:
- 聚合物化学 聚合物化学
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 分子印记制造出具有特定结合点的聚合物.
- 分子印记聚合物 (MIPs) 显示出药物发现的潜力,因为它们的选择性和强度.
- MIPs可以作为人工模仿生物受体的功能.
研究的目的:
- 评估MIPs和原生受体之间的关系.
- 评估MIP作为药物发现中的初步选工具的有用性.
- 调查MIP作为本地受体的潜在替代品.
主要方法:
- 为WAY-100635制备印制聚合物,WAY-100635是一种血清素 (5-HT) 受体对抗剂.
- 打印的聚合物P ((WAY) 作为亲和关系矩阵的评估.
- 使用P ((WAY) 亲和力矩阵查血清素受体对抗剂.
主要成果:
- 在合成P(WAY) 聚合物和原生5-HT1A受体之间观察到约相关的结合亲和力.
- 该P ((WAY) 聚合物已证明其作为选对抗剂的亲和力矩阵的有用性.
- 该研究发现了MIP和原生受体之间的识别特性中的潜在相似性.
结论:
- 这些发现支持了分子印记聚合物和原生受体之间的类比.
- 在初步药物查中,MIPs显示出作为本地受体替代物的前景.
- 这项研究有助于理解MIP在药物研究中的应用.
更多相关视频
08:49Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
相关概念视频
Drug-Receptor Interaction: Agonist
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
